View in EDS HTML Full Text PDF Full Text

Efficacy, Safety, and Durability of Long-Acting Cabotegravir and Rilpivirine in Adults With Human Immunodeficiency Virus Type 1 Infection: 5-Year Results From the LATTE-2 Study.

Saved in:
Bibliographic Details
Title: Efficacy, Safety, and Durability of Long-Acting Cabotegravir and Rilpivirine in Adults With Human Immunodeficiency Virus Type 1 Infection: 5-Year Results From the LATTE-2 Study.
Authors: Smith, Graham H R1 (AUTHOR) gsmith@mlmedical.com, Henry, W Keith2 (AUTHOR), Podzamczer, Daniel3 (AUTHOR), Masiá, Maria Del Mar4 (AUTHOR), Bettacchi, Christopher J5 (AUTHOR), Arasteh, Keikawus6 (AUTHOR), Jaeger, Hans7 (AUTHOR), Khuong-Josses, Marie-Aude8 (AUTHOR), Montes-Ramírez, Maria Luisa9 (AUTHOR), Stellbrink, Hans-Jürgen10 (AUTHOR), Yazdanpanah, Yazdan11 (AUTHOR), Richmond, Gary J12 (AUTHOR), Sutton, Kenneth C13 (AUTHOR), Zhang, Feifan14 (AUTHOR), McCoig, Cynthia C15 (AUTHOR), Clair, Marty H St16 (AUTHOR), Vandermeulen, Kati17 (AUTHOR), Solingen-Ristea, Rodica Van17 (AUTHOR), Smith, Kimberly Y18 (AUTHOR), Margolis, David A13 (AUTHOR)
Source: Open Forum Infectious Diseases. Sep2021, Vol. 8 Issue 9, p1-9. 9p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:23288957
DOI:10.1093/ofid/ofab439